ERD

CARDIATEAM | CARdiomyopathy in type 2 DIAbetes mellitus

01-03-2019

-

28-02-2026

Show more information

Organisation FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL

RESILIENCE | Remote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines.

01-06-2021

-

31-05-2026

Show more information

Organisation FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL

NeuroNanotech | Nanoplatforms for Neuroscience

01-01-2025

-

31-12-2028

Show more information

Organisation FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL

PurinesDX | Interdisciplinary training network on the purinergic P2X7 receptor to control neuroinflammation and hyperexcitability in brain diseases.

01-09-2017

-

31-08-2021

Show more information

Organisation FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL

MORPHEUS | PROGNOSIS IMPROVEMENT OF UNPROVOKED VENOUS THROMBOEMBOLISM USING PERSONALIZED ANTICOAGULANT THERAPY

01-12-2023

-

30-11-2028

Show more information

Organisation FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL

PANCAID | PANcreatic CAncer Initial Detection via liquid biopsy

01-01-2023

-

31-12-2027

Show more information

Organisation FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL

IN-ARMOR | THERAPEUTIC EPIGENETIC ENHANCEMENT OF THE INNATE IMMUNITY TO EFFECTIVELY COMBAT ANTIMICROBIAL RESISTANCE [IN-ARMOR]

01-05-2023

-

30-04-2027

Show more information

Organisation FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL

NanoTBTech | Nanoparticles-based 2D thermal bioimaging technologies

01-09-2018

-

28-02-2022

Show more information

Organisation FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL

VISION | Strategies to strengthen scientific excellence and innoVation capacIty for early diagnoSIs of gastrOintestinal caNcers

01-10-2019

-

30-06-2023

Show more information

Organisation FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL

TechConnect | TechConnect: Assessing and Strengthening Human-Tech Skill Complementarity in the Digital Landscape

01-10-2024

-

30-09-2027

Show more information

Organisation FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL

METEOR study | MicrobiomE-associaTEd boosters Of immune Responses (METEOR study): experimental charac-terization and clinical exploitation.

01-09-2023

-

31-12-2025

Show more information

Organisation FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL

REPLAY | Analysing the role of history, chance and selection on the evolution of plasmid-mediated antibiotic resistance

01-09-2020

-

31-10-2022

Show more information

Organisation FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL

Projects overview

Selected filters:

CARDIATEAM | CARdiomyopathy in type 2 DIAbetes mellitus

RESILIENCE | Remote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines.

NeuroNanotech | Nanoplatforms for Neuroscience

PurinesDX | Interdisciplinary training network on the purinergic P2X7 receptor to control neuroinflammation and hyperexcitability in brain diseases.

MORPHEUS | PROGNOSIS IMPROVEMENT OF UNPROVOKED VENOUS THROMBOEMBOLISM USING PERSONALIZED ANTICOAGULANT THERAPY

PANCAID | PANcreatic CAncer Initial Detection via liquid biopsy

IN-ARMOR | THERAPEUTIC EPIGENETIC ENHANCEMENT OF THE INNATE IMMUNITY TO EFFECTIVELY COMBAT ANTIMICROBIAL RESISTANCE [IN-ARMOR]

NanoTBTech | Nanoparticles-based 2D thermal bioimaging technologies

VISION | Strategies to strengthen scientific excellence and innoVation capacIty for early diagnoSIs of gastrOintestinal caNcers

TechConnect | TechConnect: Assessing and Strengthening Human-Tech Skill Complementarity in the Digital Landscape

METEOR study | MicrobiomE-associaTEd boosters Of immune Responses (METEOR study): experimental charac-terization and clinical exploitation.

REPLAY | Analysing the role of history, chance and selection on the evolution of plasmid-mediated antibiotic resistance